The Role of High Dose Rate Brachytherapy in the Palliation of Symptom in Patients with Non-Small Cell Lung Cancerenglish
Version: 3 ID: 7-16 Jun 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Adult patients with symptomatic endobronchial disease in non-small cell lung cancer.
- Is there a role for high dose rate endobronchial brachytherapy (HDREB) in the palliation of respiratory symptoms in patients with non-small cell lung cancer?
- If so, what is the optimal dose of HDREB in this setting?
Summary (PDF) (169.31 KB)
Full Report (PDF) (1.07 MB)